TREM2 (UniProt: Q9NZC2)

Triggering Receptor Expressed on Myeloid cells 2 (TREM2) protein is a new biomarker of AD proposed recently as the Loss-of-function mutations cause 4.9-fold increased risk of AD1. In the human brain, TREM2 is exclusively expressed in the microglia. It could interact with various proteins and ligands, such as APOE and β-amyloid (Aβ) peptides, and activate the signalling pathway through DNAX-activation protein 12 (DAP12)2,3.

Mutation Viewer
Please choose a missense mutation of interest from the heatmap, and click to get protein structural information.

Mutation information info_outline

Residue environment info_outline

Mutation effect info_outline

Wild-type :

Position :

Mutant :

Prediction :

Confidence :

Secondary structure :

RSA :

phi :

psi :

pLDDT :

Protein stability :

PSSM :

AlphaMissense score :

ESM1b score :

CPT-1 score :

Wild-type Structure Viewer

Residue label

Interactions

Clash

VDW

Hydrogen Bond

Ionic

Aromatic

Hydrophobic

Carbonyl

Polar

PI interaction

Interaction Changes
Contact types - mutation Wild-type structure Mutant structure
Clash
VDW
Hydrogen Bond
Ionic
Aromatic
Hydrophobic
Carbonyl
Polar
PI interaction
expand_lessBack